Skip to main content

Site notifications

Guideline on excipients in the dossier for application for marketing authorisation of a medicinal product

We have adopted this International Scientific Guideline - EMEA/CHMP/QWP/396951/2006.

Last updated

Help us improve the Therapeutic Goods Administration site